Orca Capital AG - 22 Apr 2025 SCHEDULE 13G/A Report for Can-Fite BioPharma Ltd. Ordinary Shares, no par value (CANF)

Filing Manager: Orca Capital AG
Reporting Manager: Orca Capital AG
Security: Can-Fite BioPharma Ltd. Ordinary Shares, no par value
Symbol: CANF
Shares outstanding: 3,838,602,439 shares
Disclosed Ownership: 157,382,700 shares
Ownership: 4.1%
Form type: SCHEDULE 13G/A
Filing time: 23 Apr 2025, 16:30:25 UTC
Date of event: 22 Apr 2025
Previous filing: 16 Apr 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Orca Capital AG	4.1%	157,382,700	157,382,700	0	/s/ Thomas Konig	Thomas Konig/Director